Solanezumab 是一种针对amyloid-β (Aβ) 肽中间结构域的人源化单克隆 IgG1 抗体。Solanezumab 具有阿尔茨海默症研究的潜力。
| 生物活性 | Solanezumab is a humanized monoclonalIgG1antibody directed against the mid-domain of theamyloid-β(Aβ)peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1]. |
| 分子量 | |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com